Abstract | OBJECTIVE: STUDY DESIGN: A total of 42 female rats were equally divided into 6 experimental groups; group 1: sham operation, group 2: 3-h ischemia, group 3 and 4: 3-h ischemia, 3-h reperfusion, group 5 and 6: 3-h ischemia, 24h reperfusion. In group 4 and group 6, 30 min before reperfusion, infliximab was administered intraperitoneally at a dose of 5mg/kg. Bilateral ovaries were removed for histopathologic and biochemical analysis. Serum MDA (sMDA), tissue MDA ( tMDA), serum NO (sNO), tissue NO (tNO) and serum catalase concentrations were analyzed. Tissue damage of ovarian tissue was scored by histological examination. RESULTS: The infliximab administration significantly lowered the sNO, tNO and sMDA concentrations in group 4 compared to group 3 (p=0.041, p=0.025 and p=0.035, respectively). sNO, tNO and sMDA concentrations were also lower in group 6 when compared to group 5, but this differences were not significant (p>0.05). On the other hand, tMDA concentrations were lower in infliximab-applied groups when compared to ischemia/reperfusion groups (group 3 vs. 4 and 5 vs. 6) (p=0.045 and p=0.048, respectively). Moreover, histopathologic tissue damage scores in infliximab administration groups were significantly lower than in ischemia/reperfusion groups (p<0.001). CONCLUSION:
Infliximab attenuates I/R-induced ovarian tissue injury in rats subjected to ischemia/reperfusion.
|
Authors | Remzi Abali, Nicel Tasdemir, Mehmet Aytac Yuksel, Savas Guzel, Meltem Oznur, Burcin Nalbantoglu, Ufuk Goker Tasdemir |
Journal | European journal of obstetrics, gynecology, and reproductive biology
(Eur J Obstet Gynecol Reprod Biol)
Vol. 171
Issue 2
Pg. 353-7
(Dec 2013)
ISSN: 1872-7654 [Electronic] Ireland |
PMID | 24169036
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Antibodies, Monoclonal
- Antioxidants
- Nitric Oxide
- Malondialdehyde
- Infliximab
- Catalase
|
Topics |
- Animals
- Antibodies, Monoclonal
(therapeutic use)
- Antioxidants
(therapeutic use)
- Catalase
(blood)
- Female
- Infliximab
- Malondialdehyde
(metabolism)
- Nitric Oxide
(metabolism)
- Ovary
(injuries)
- Rats
- Rats, Sprague-Dawley
- Reperfusion Injury
(drug therapy, pathology, prevention & control)
- Torsion Abnormality
(therapy)
|